Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Great Tree Pharmacy Co's quarterly finished goods
increased
from Sep. 2025 (NT$3,492 Mil) to Dec. 2025 (NT$3,689 Mil) and
increased
from Dec. 2025 (NT$3,689 Mil) to Mar. 2026 (NT$3,967 Mil).
Great Tree Pharmacy Co's annual finished goods
increased
from Dec. 2023 (NT$2,794 Mil) to Dec. 2024 (NT$3,165 Mil) and
increased
from Dec. 2024 (NT$3,165 Mil) to Dec. 2025 (NT$3,689 Mil).
Great Tree Pharmacy Co Inventories, Finished Goods Historical Data
* Premium members only.
The historical data trend for Great Tree Pharmacy Co's Inventories, Finished Goods can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Great Tree Pharmacy Co Inventories, Finished Goods Chart
What does a Inventories, Finished Goods of NT$3,967 Mil mean?
Great Tree Pharmacy Co (ROCO:6469) has a Inventories, Finished Goods of NT$3,967 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Great Tree Pharmacy Co and its competitors.
Is Great Tree Pharmacy Co's Inventories, Finished Goods too high?
Great Tree Pharmacy Co's current Inventories, Finished Goods is NT$3,967 Mil. Overall, Great Tree Pharmacy Co has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Great Tree Pharmacy Co's Inventories, Finished Goods compare to competitors?
Great Tree Pharmacy Co's Inventories, Finished Goods of NT$3,967 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Healthcare Providers & Services company?
A good Inventories, Finished Goods depends on the Healthcare Providers & Services industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Great Tree Pharmacy Co and its competitors. Great Tree Pharmacy Co's current Inventories, Finished Goods is NT$3,967 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Great Tree Pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Great Tree Pharmacy Co (ROCO:6469) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$178.32, compared to a current price of NT$78.20 — trading 56.1% below its estimated fair value. The current Inventories, Finished Goods is NT$3,967 Mil. Great Tree Pharmacy Co's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Great Tree Pharmacy Co (ROCO:6469), the current Inventories, Finished Goods is NT$3,967 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Great Tree Pharmacy Co (ROCO:6469) Overvalued in 2026?
Based on GuruFocus' analysis, Great Tree Pharmacy Co stock appears to be undervalued.
The current stock price of NT$78.20 is trading 56.1% below its estimated GF Value™ of NT$178.32.
GuruFocus considers Great Tree Pharmacy Co to be Significantly Undervalued.
Key valuation signals for ROCO:6469:
Inventories, Finished Goods: NT$3,967 Mil
GF Value™: NT$178.32 vs. price of NT$78.20 (56.1% below fair value)
No single metric tells the full story. See the ROCO:6469 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Great Tree Pharmacy Co Ltd engages in management and trading of various drugs, health supplements, maternity and infant products, and cosmetics products. It also provides coordinated medicine procurement services to various clinics, outpatient centers, and medical communities. Besides, it is also an agency for domestic and foreign health care products sold in clinics, outpatient centers, and medical communities. Its products include infant formula, baby diapers, Maternal and Infant Related, Adult drinks, Nutrition and health care, Body care, Daily Necessities, medical equipment, and Pet products.
69GF Score
Get the complete analysis for ROCO:6469
Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6469 has been successfully added to your 
